Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Enright Patrick G
Relationship:   10% Owner
City:   Burlingame
State:   CA
   
Insider Summary:
  
   
Companies Owned :   16    
Direct Shares   3,308,185    

Indirect Shares

  27,432,603      
Direct Value   $9,946,560    

Indirect Value

  $114,800,011      
Total Shares   30,740,788      
Total Value   $124,746,571      


Molecular Templates, Inc.
 $298 Sequenom Inc
 $0 Corcept Therapeutics Inc
 $7,648,373 Jazz Pharmaceuticals Inc
 $2,288,769 Aptinyx Inc.
 $9,120 Eargo, Inc.
 $0 Molecular Templates, Inc.
 $298 Sequenom Inc
 $0 Corcept Therapeutics Inc
 $7,648,373 Jazz Pharmaceuticals Inc
 $2,288,769 Aptinyx Inc.
 $9,120 Eargo, Inc.
 $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    6   
    1    

     Stock price went up :

    5   
    1    
     Stock price went down :
    1   
    0    
   
     Gain/Loss Ratio :
   5.0   
   1.0   
     Percentage Gain/Loss :
   95.0%
 101.2%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Molecular Templates, Inc. MTEM Director 2006-04-20 496 2007-03-01 0    Premium*  
            Sequenom Inc SQNM Director 2006-12-07 771 2006-12-07 3,333,333    Premium*  
            Corcept Therapeutics Inc CORT Director 2017-03-16 272,281 2017-03-16 114,675    Premium*  
            Jazz Pharmaceuticals Inc JAZZ Director 2023-08-14 20,946 2022-08-08 2,000    Premium*  
            Esperion Therapeutics, Inc. ESPR Director 2013-07-01 0 2015-03-19 18,361    Premium*  
            Collegium Pharmaceutical, Inc COLL 10% Owner 2015-05-12 0 2015-05-12 65,270    Premium*  
            Aimmune Therapeutics, Inc. AIMT Director 2020-10-13 0 2020-10-10 0    Premium*  
            Aptinyx Inc. APTX Director 2020-01-10 95,000 2020-01-10 3,356,746    Premium*  
            Tricida, Inc. TCDA 2018-07-02 0 2018-07-02 3,019,734    Premium*  
            Venus Concept Inc VERO 10% Owner 0 2019-11-07 3,666,119    Premium*  
            89bio, Inc. ETNB 10% Owner 2019-11-11 0 2020-11-16 891    Premium*  
            Sierra Oncology Inc SRRA 10% Owner 2020-01-29 0 2022-01-25 1,964,771    Premium*  
            Inozyme Pharma, Inc. INZY 10% Owner 2020-07-28 0 2022-04-19 4,174,379    Premium*  
            Eargo, Inc. EAR 10% Owner 2021-04-14 2,918,691 2021-04-14 5,012    Premium*  
            Vera Therapeutics, Inc. VERA Director, 10% Owner 2021-05-18 0 2023-02-06 5,144,212    Premium*  
            Lexeo Therapeutics, Inc. LXEO 10% Owner 2023-11-07 0 2023-11-07 2,567,100    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2015-08-10 4 AS $180.05 $1,820,177 I/I (10,000) 5,500 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2015-08-10 4 AS $179.98 $144,178 D/D (801) 2,159 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2015-06-01 4 S $177.82 $1,787,336 I/I (10,000) 5,893 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2015-07-06 4 S $175.81 $1,771,055 I/I (10,000) 5,696 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2018-08-10 4 S $175.13 $239,057 D/D (1,365) 16,469 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2015-03-02 4 S $172.60 $1,760,031 I/I (10,000) 6,482 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2014-12-01 4 S $170.96 $1,727,424 I/I (10,000) 7,072 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2014-11-10 4 S $170.90 $1,710,858 I/I (10,000) 7,268 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2014-12-12 4 S $170.32 $400,603 D/D (2,343) 1,650 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2015-04-06 4 S $168.31 $1,691,419 I/I (10,000) 6,286 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2018-09-06 4 AS $167.96 $1,709,565 D/D (10,130) 16,469 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2015-08-27 4 S $167.87 $71,345 D/D (425) 1,734 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2015-02-10 4 S $166.45 $1,668,518 I/I (10,000) 6,679 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2015-09-01 4 S $164.50 $1,659,852 I/I (10,000) 5,304 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2014-09-02 4 S $162.71 $1,629,387 I/I (10,000) 7,661 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2015-01-05 4 S $159.68 $1,602,483 I/I (10,000) 6,875 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2014-10-06 4 S $159.47 $1,605,633 I/I (10,000) 7,465 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2022-08-08 4 S $152.33 $165,883 D/D (1,089) 24,086 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2014-02-28 4 S $150.50 $83,507,487 I/I (547,867) 7,858 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2015-12-02 4 S $148.49 $62,960 D/D (424) 1,310 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2017-08-25 4 AS $148.40 $52,088 D/D (351) 1,717 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2014-03-03 4 S $147.87 $1,772,775 I/I (11,761) 0 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2015-12-01 4 S $145.96 $1,465,910 I/I (10,000) 4,716 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2020-11-12 4 AS $145.81 $1,456,738 D/D (9,929) 20,368 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2017-08-11 4 S $142.36 $94,248 D/D (662) 2,068 0 -

  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed